Andrew Lo - Nov 17, 2025 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Will Solis, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Nov 17, 2025
Transactions value $
-$6,319,662
Form type
4
Date filed
11/19/2025, 05:08 PM
Previous filing
Jun 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lo Andrew Director C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO /s/ Will Solis, Attorney-in-Fact 2025-11-19 0001679076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BBIO Common Stock Sale -$2.45M -36.8K -67.29% $66.63 17.9K Nov 17, 2025 Direct F1
transaction BBIO Common Stock Sale -$255K -3.8K -21.23% $67.06 14.1K Nov 17, 2025 Direct F2
transaction BBIO Common Stock Sale -$1.57M -24K -22.74% $65.23 81.6K Nov 18, 2025 By Andrew W. Lo and Nancy N. Lo JTWROS F3
transaction BBIO Common Stock Sale -$2.05M -31K -37.99% $66.05 50.6K Nov 18, 2025 By Andrew W. Lo and Nancy N. Lo JTWROS F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price of the shares sold from $65.975 to $66.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F2 Represents the weighted average sale price of the shares sold from $66.975 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F3 Represents the weighted average sale price of the shares sold from $64.58 to $65.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
F4 Represents the weighted average sale price of the shares sold from $65.58 to $66.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Remarks:

Exhibit 24 - Power of Attorney